Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m

View source ↗

Summary

Clinical trial update evaluating talazoparib-treated adults with HER2-negative metastatic breast cancer and germline BRCA1/2 mutations, reporting completed stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Breast Cancer, Breast Neoplasms | Status: COMPLETED | Results posted: 2024-02-16